Breast Cancer Sequencing Study Finds Many Metastatic Mutations are Undetectable in Primary Tumor
October 13, 2009
Breast Cancer Sequencing Study Finds Many Metastatic Mutations are Undetectable in Primary Tumor
According to the BC Cancer Foundation, the research team is now sequencing the genomes of several hundred so-called triple negative breast tumors as part of an effort to build "a comprehensive genomic map of breast cancer" from 2,000 samples.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- New Products
October 20, 2009 / In Sequence - BCCA's Genome Sciences Centre Joins Illumina Genome Network
December 20, 2011 / In Sequence - Last Week's Clinical Sequencing Papers of Note
August 31, 2011 / Clinical Sequencing News - Haplotype-Resolved Genome Illustrates Potential Impact of Phase on Function and Disease
August 30, 2011 / In Sequence - Helicos Expands License for Arizona State University Patents to Include Non-Optical Detection Methods
August 30, 2011 / In Sequence